Interestingly, recent evidence showed the pleiotropic effect of PCSK9 ion atherosclerosis progression, beyond its lipid-lowering ability, potentially by being involved in platelet activation, a key event during the emergence of atherosclerosis initiation, atherogenesis, and atherothrombosis, which lead to the development of MI. This evidence concerns the gene PCSK9 and atherosclerosis.